Pilot studies on the effects of a phosphomolybdic tungstic acid compound (PTMC) on spontaneous malignant tumours in dogs.
Owen
L N
LN
Owen
A G
AG
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D008982:Molybdenum / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy / Q000662:veterinary*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D014414:Tungsten / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009942:Organometallic Compounds; D008982:Molybdenum; D014414:Tungsten